JPWO2023201421A5 - - Google Patents
Info
- Publication number
- JPWO2023201421A5 JPWO2023201421A5 JP2024562088A JP2024562088A JPWO2023201421A5 JP WO2023201421 A5 JPWO2023201421 A5 JP WO2023201421A5 JP 2024562088 A JP2024562088 A JP 2024562088A JP 2024562088 A JP2024562088 A JP 2024562088A JP WO2023201421 A5 JPWO2023201421 A5 JP WO2023201421A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- independently selected
- pharmaceutically acceptable
- compound according
- prodrug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263332450P | 2022-04-19 | 2022-04-19 | |
| US63/332,450 | 2022-04-19 | ||
| PCT/CA2023/050521 WO2023201421A1 (en) | 2022-04-19 | 2023-04-18 | Indoline derivatives as serotonergic agents useful for the treatment of disorders related thereto |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025513461A JP2025513461A (ja) | 2025-04-24 |
| JP2025513461A5 JP2025513461A5 (https=) | 2026-04-23 |
| JPWO2023201421A5 true JPWO2023201421A5 (https=) | 2026-04-23 |
Family
ID=88418733
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024562090A Pending JP2025513462A (ja) | 2022-04-19 | 2023-04-18 | セロトニン作動薬としてのインドリン誘導体に関連する障害の治療に有用なセロトニン作動薬としてのインドリン誘導体 |
| JP2024562088A Pending JP2025513461A (ja) | 2022-04-19 | 2023-04-18 | セロトニン作動薬としてのインドリン誘導体に関連する障害の治療に有用なセロトニン作動薬としてのインドリン誘導体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024562090A Pending JP2025513462A (ja) | 2022-04-19 | 2023-04-18 | セロトニン作動薬としてのインドリン誘導体に関連する障害の治療に有用なセロトニン作動薬としてのインドリン誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20250353827A1 (https=) |
| EP (2) | EP4511369A4 (https=) |
| JP (2) | JP2025513462A (https=) |
| KR (2) | KR20250034020A (https=) |
| CN (2) | CN119546591A (https=) |
| AU (2) | AU2023258059A1 (https=) |
| CA (2) | CA3248179A1 (https=) |
| IL (2) | IL316401A (https=) |
| MX (2) | MX2024012865A (https=) |
| WO (2) | WO2023201421A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL318929A (en) * | 2022-08-29 | 2025-04-01 | Mindset Pharma Inc | Indoline derivatives as serotonergic agents useful for the treatment of related disorders |
| WO2025104491A1 (en) * | 2023-11-14 | 2025-05-22 | Mindset Pharma Inc. | Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto |
| WO2025123137A1 (en) * | 2023-12-15 | 2025-06-19 | 10763942 Canada Inc. (Dba. Purminds Neuropharma) | Heterocyclic compounds and methods of preparation thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2737725B1 (fr) * | 1995-08-08 | 1997-10-31 | Valentonine | Nouveaux derives acyles de la melatonine et d'analogues melatoninergiques, leur procede de preparation et leur utilisation en tant que medicament |
| EP0944595B1 (en) * | 1996-11-26 | 2003-10-01 | NPS Allelix Corp. | 5-cyclo indole compounds as 5-ht1d receptor ligands |
| CZ295937B6 (cs) * | 1997-07-25 | 2005-12-14 | H. Lundbeck A/S | Indolové nebo 2,3-dihydroindolové deriváty |
| GB9819033D0 (en) * | 1998-09-01 | 1998-10-28 | Cerebrus Ltd | Chemical compounds VI |
| US6608079B1 (en) * | 1998-12-11 | 2003-08-19 | Eli Lilly And Company | Indole derivatives and their use as 5-HT1F agonists |
| AU2003236207A1 (en) * | 2002-05-31 | 2003-12-19 | H. Lundbeck A/S | The hydrochloride of (s)-(+)-3-(1-(2-(1-acetyl-2,3-dihydro-1h-indol-3-yl)ethyl)-1,2,3,6-tetrahydropyridin-4-yl)-6-chloro-1h-indole |
| WO2005084664A1 (ja) * | 2004-03-08 | 2005-09-15 | Kanazawa University Technology Licensing Organization Ltd. | インドール誘導体及びその用途 |
| CL2007002166A1 (es) * | 2006-07-24 | 2008-01-25 | Tetralogic Pharm Corp | Compuestos derivados de heterociclos de nitrogeno, antagonistas de los inhibidores de las proteinas de la apoptosis; sus composiciones farmaceuticas; y uso de dichos compuestos para el tratamiento del cancer. |
| MX2022009528A (es) * | 2020-02-04 | 2022-11-14 | Mindset Pharma Inc | Derivados de 3-pirrolidina-indol como agentes psicodélicos serotoninérgicos para el tratamiento de trastornos del snc. |
-
2023
- 2023-04-18 KR KR1020247038407A patent/KR20250034020A/ko active Pending
- 2023-04-18 WO PCT/CA2023/050521 patent/WO2023201421A1/en not_active Ceased
- 2023-04-18 EP EP23790806.6A patent/EP4511369A4/en active Pending
- 2023-04-18 US US18/857,230 patent/US20250353827A1/en active Pending
- 2023-04-18 JP JP2024562090A patent/JP2025513462A/ja active Pending
- 2023-04-18 JP JP2024562088A patent/JP2025513461A/ja active Pending
- 2023-04-18 CA CA3248179A patent/CA3248179A1/en active Pending
- 2023-04-18 AU AU2023258059A patent/AU2023258059A1/en active Pending
- 2023-04-18 IL IL316401A patent/IL316401A/en unknown
- 2023-04-18 CA CA3248170A patent/CA3248170A1/en active Pending
- 2023-04-18 EP EP23790804.1A patent/EP4511360A4/en active Pending
- 2023-04-18 KR KR1020247038406A patent/KR20250036719A/ko active Pending
- 2023-04-18 AU AU2023255414A patent/AU2023255414A1/en active Pending
- 2023-04-18 IL IL316416A patent/IL316416A/en unknown
- 2023-04-18 US US18/857,234 patent/US20260083703A1/en active Pending
- 2023-04-18 WO PCT/CA2023/050523 patent/WO2023201423A1/en not_active Ceased
- 2023-04-18 CN CN202380048473.6A patent/CN119546591A/zh active Pending
- 2023-04-18 CN CN202380048482.5A patent/CN119522212A/zh active Pending
-
2024
- 2024-10-17 MX MX2024012865A patent/MX2024012865A/es unknown
- 2024-10-17 MX MX2024012864A patent/MX2024012864A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2935476T3 (es) | Esteroides neuroactivos, composiciones y usos de los mismos | |
| JP7569412B2 (ja) | ＣＮＳ障害を処置するためのジュウテリウム化された２１－［４－シアノ－ピラゾール－１－イル］－１９－ノル－プレガン－３．α－オール－２０－オン誘導体 | |
| IL295371A (en) | Psilocyin derivatives as serotonergic psychedelics for the treatment of central nervous system disorders | |
| JPWO2021155468A5 (https=) | ||
| US20210113590A1 (en) | Compositions and methods for treating cns disorders | |
| US20210369734A1 (en) | Compounds and methods of their use | |
| IL316401A (en) | Indoline derivatives as estrogenic agents for the treatment of disorders | |
| JP6215971B2 (ja) | てんかん又はてんかん−関連症侯群の予防又は治療用フェニルアルキルカルバメート化合物｛ｐｈｅｎｙｌａｌｋｙｌｃａｒｂａｍａｔｅｃｏｍｐｏｕｎｄｓｆｏｒｕｓｅｉｎｐｒｅｖｅｎｔｉｎｇｏｒｔｒｅａｔｉｎｇｅｐｉｌｅｐｓｙｏｒｅｐｉｌｅｐｓｙ−ｒｅｌａｔｅｄｓｙｎｄｒｏｍｅ｝ | |
| ES3041367T3 (en) | Eaat2 activators and methods of using thereof | |
| EP3030239A2 (en) | Urea derivatives and uses thereof | |
| JP2024540583A (ja) | Ｋｖ７．２エンハンサーとしてのピリジン化合物 | |
| JPWO2023201421A5 (https=) | ||
| JPWO2023201423A5 (https=) | ||
| AR034158A1 (es) | Derivados de 1-aminobutano-3-ol sustituidos, procedimientos para su preparacion, medicamentos que contienen estos compuestos y el uso de derivados de 1-aminobutano-3-ol sustituidos para la preparacion de medicamentos | |
| JPWO2022120475A5 (https=) | ||
| JP2019535715A5 (https=) | ||
| RU2024134395A (ru) | Производные индолина в качестве серотонинергических агентов, подходящих для лечения расстройств, связанных с ними | |
| JPWO2022183287A5 (https=) | ||
| WO2014197313A2 (en) | Novel compounds and uses thereof | |
| JPWO2022183288A5 (https=) | ||
| JP2025506201A (ja) | 新規なビシクロペンタン誘導体 | |
| JP7430175B2 (ja) | オキサジアゾールを含む化合物及びそれを含む医薬組成物 | |
| AR034159A1 (es) | Derivados de 5-amino-1-penten-3-ol sustituidos, procedimiento para su preparacion, medicamentos que contienen estos derivados y su uso para la preparacion de medicamentos |